PE20000887A1 - Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo - Google Patents
Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del cicloInfo
- Publication number
- PE20000887A1 PE20000887A1 PE1999000799A PE00079999A PE20000887A1 PE 20000887 A1 PE20000887 A1 PE 20000887A1 PE 1999000799 A PE1999000799 A PE 1999000799A PE 00079999 A PE00079999 A PE 00079999A PE 20000887 A1 PE20000887 A1 PE 20000887A1
- Authority
- PE
- Peru
- Prior art keywords
- progestagen
- cycle control
- good cycle
- allows good
- type contraceptive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN KIT ANTICONCEPTIVO QUE COMPRENDE MEDIOS PARA LA ADMINISTRACION DIARIA DE PROGESTAGENO, CARACTERIZADO POR ESTAR DIVIDIDOS EN DOS FASES: I) ADMINISTRACION DIARIA DE 10 A 20 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD LO MAS BAJA POSIBLE PARA INHIBIR LA OVULACION; Y, II) ADMINISTRACION DIARIA AL MENOS DURANTE 7 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD QUE ES AL MENOS EL DOBLE DE LA FASE I), PERO NO MAS BAJA QUE LA DOSIS REQUERIDA PARA CAUSAR LA TRANSFORMACION DEL ENDOMETRIO. DONDE, EL PROGESTAGENO SE SELECCIONA DEL GRUPO CONSISTENTE EN DESOGESTREL, ORG 30659, LEVONORGESTREL Y GESTODENE. ASIMISMO, I) Y II) COMPRENDEN 14 UNIDADES DE DOSIFICACION DIARIAS. CON ESTE REGIMEN SE OBTIENE UN BUEN CONTROL DEL CICLO Y EFICACIA ANTICONCEPTIVA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202699 | 1998-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000887A1 true PE20000887A1 (es) | 2000-09-15 |
Family
ID=8234025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000799A PE20000887A1 (es) | 1998-08-11 | 1999-08-09 | Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5619399A (es) |
| PE (1) | PE20000887A1 (es) |
| WO (1) | WO2000009136A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2745541C (en) * | 2008-12-12 | 2016-11-08 | Laboratoire Hra-Pharma | A method for contraception |
| NZ595790A (en) * | 2009-04-14 | 2013-11-29 | Hra Pharma Lab | Method for on-demand contraception |
| EP2730284A1 (en) * | 2012-11-12 | 2014-05-14 | Naari AG | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
| US11679114B2 (en) * | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4066757A (en) * | 1973-03-26 | 1978-01-03 | Ortho Pharmaceutical Corporation | Oral contraceptive regimen |
| IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
| DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
-
1999
- 1999-08-04 WO PCT/EP1999/005610 patent/WO2000009136A1/en active Application Filing
- 1999-08-04 AU AU56193/99A patent/AU5619399A/en not_active Abandoned
- 1999-08-09 PE PE1999000799A patent/PE20000887A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000009136A1 (en) | 2000-02-24 |
| AU5619399A (en) | 2000-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20060485A1 (es) | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
| ES2190472T3 (es) | Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno. | |
| AR046671A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
| CA2468748A1 (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| BR9916579A (pt) | Contraceptivo oral trifásico | |
| AR031563A1 (es) | Una composicion farmaceutica para emplear en el tratamiento de trastornos menopausicos o posmenopausicos de estrogenos y acetato de medroxiprogesterona, una unidad de dosificacion farmaceutica y uso de una combinacion de estrogenos conjugados y acetato de medroxiprogesterona para la manufactura de u | |
| PL182544B1 (pl) | Zestaw do antykoncepcji hormonalnej | |
| ES2116804T3 (es) | Preparado polifasico para la anticoncepcion basado en estrogenos naturales. | |
| BR9813262A (pt) | Terapia de progestina com sangramento controlado | |
| NO986104L (no) | Progesteron-anti-progesteron regimer | |
| KR920011514A (ko) | 프로게스토겐만을 함유하는 피임제 | |
| KR970704451A (ko) | 기능부전성 자궁출혈 치료용 약제의 제조에 유용한 프로게스테론 길항제(Progesterone Antagonists Useful for Preparing Medicaments for Treating Dysfunctional Uterine Bleeding) | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| ES2348038T5 (es) | Preparado polifásico para la contracepción sobre la base de un estrógeno natural | |
| RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
| NO20061937L (no) | Utvidet trefaseprevansjonskur | |
| PE20000887A1 (es) | Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo | |
| PE20031047A1 (es) | Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama | |
| BR0009476A (pt) | Esteróides imunomoduladores, em particular hemidrato de 16 alfa-bromoepiandrosterona | |
| KR920019350A (ko) | 자기면역질환요법을 위한 약제조성물 | |
| PE20070555A1 (es) | Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
| NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen | |
| UY26966A1 (es) | Uso de antiprogestinas para la inducción de apoptosis en una célula | |
| ECSP993091A (es) | Regimen anticonceptivo del tipo "solo progestageno" que permite un buen control del ciclo y eficacia anticonceptiva, donde se suministra el progestageno en dos fases | |
| KR960700726A (ko) | 수정의 방지 또는 억제방법(method of preventing of inhibting fertilization) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |